"We're very excited about this addition to our EU animal health business." says Christian Vervaet (DVM), EU Sales Director Huvepharma®. "This acquisition furthers Huvepharma®'s strategy in creating a balanced portfolio of animal health products and enhancing our presence both in Europe and our international markets. We will be in a better position to serve our customers with an extended high-quality product range, the Qalian team and the complementary production facilities."
"We're pleased to join Huvepharma®'s internationally recognized animal health company. This move will provide us with resources to quickly bring new solutions to veterinarians and producers. It will also allow us to accelerate the international development of our ranges of products." says Alex Klein (DVM), General Manager Qalian France.
The acquisition includes Qalian and Merial production facilities in Segré, St Etienne in France and Carpi in Italy, including the branded veterinary pharmaceuticals (drugs & premix), animal dietetics and hygiene product lines.
"Huvepharma® and Qalian are strong, complementary businesses focussed on providing real solutions for animal health," Vervaet says.
About Qalian and Merial: Qalian & Meriel represent the Animal Health division of Neovia (nutrition & animal health subsidiary of InVivo Group). Qalian's activities are focused on livestock animals. Qalian is a leading player in France and abroad, providing customers with veterinary drugs, medicated premix, animal dietetics and hygiene solutions.
